96. Crohn disease Clinical trials / Disease details


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00304252
(ClinicalTrials.gov)
November 200114/3/2006Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's DiseaseA Phase II, Multicenter, Randomised, Double-blind, Placebo Controlled, Dose Finding Study of Subcutaneously Administered Interferon Beta-1a for Maintenance of Remission in Patients With Crohn's DiseaseCrohn's DiseaseDrug: Interferon beta-1aEMD SeronoNULLTerminated18 YearsN/ABoth192Phase 2Germany;Italy;Sweden;Switzerland;United Kingdom